The Gross Margin of WuXi Biologics (Cayman) Inc (2269.HK) is 40.97%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 40.97% |
| 2023-12-31 | 40.08% |
| 2022-12-31 | 44.04% |
| 2021-12-31 | 46.93% |
| 2020-12-31 | 45.13% |
| 2019-12-31 | 41.64% |
| 2018-12-31 | 40.16% |
| 2017-12-31 | 40.80% |
| 2016-12-31 | 39.34% |
| 2015-12-31 | 32.44% |